Insider Trading › SBFM › Insiders
Sunshine Biopharma Inc.
SBFM·Nasdaq·
United States·Insider activity
United States·Insider activity$0.40
-0.02 (-5.28%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
SBFM
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
SBFMS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of SBFM were filed in the last 180 days. Newest filing Mar 5, 2024 (2 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by SBFM insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
7Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of SBFM common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
7 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Slilaty Steve N.Chief Executive Officer · Director · 10% owner | Purchase | +100.0K | $0.10 | $10K | 130.0Kdirect | Mar 4, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Slilaty Steve N.Chief Executive Officer · Director · 10% owner | Purchase | +20.0K | n/c | — | 30.0Kdirect | Feb 8, 2024 | Feb 12, 2024 | Form 4 ↗ |
| Sebaaly CamilleCFO/Secretary | Purchase | +30.0K | $0.76 | $23K | 174.5Kdirect | Nov 30, 2022 | Dec 2, 2022 | Form 4 ↗ |
| Sebaaly CamilleCFO/Secretary | Purchase | +25.0K | $1.22 | $31K | 144.5Kdirect | Jun 3, 2022 | Jun 6, 2022 | Form 4 ↗ |
| Slilaty Steve N.Chief Executive Officer · Director | Purchase | +253.1K | n/c | — | 30.6Mindirect | Apr 12, 2016 | Apr 26, 2016 | Form 4 ↗ |
| Slilaty Steve N.Chief Executive Officer · Director · 10% owner | Purchase | +500.0K | n/c | — | 500.0Kdirect | May 27, 2015 | Jun 1, 2015 | Form 4 ↗ |
| Slilaty Steve N.Chief Executive Officer · Director · 10% owner | Sale | −2.6M | n/c | — | 31.5Mindirect | Sep 4, 2012 | Sep 7, 2012 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →